Rupesh Kotecha, M.D., is a board-certified radiation oncologist and Chief of Radiosurgery in the Department of Radiation Oncology and Director of the Central Nervous System (CNS) Metastasis program at Miami Cancer Institute. He is a professor in the departments of radiation oncology and translational medicine at the FIU Herbert Wertheim College of Medicine and an adjunct faculty in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He has specialized training and experience in utilizing the latest techniques in radiation therapy for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife, LINAC-based, ZAP-X and GammaKnife radiosurgery,. He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy. During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has delivered over 200 oral and poster presentations, invited to give over 150 national and international presentations, and has over 200 publications in book chapters and peer-reviewed journals. His research bandwidth spans investigator-initiated studies to multi-center trials to national cooperative group clinical protocols. Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group, coordinates the NCI Glioblastoma Clinical Interest Group, and is a course director for the annual Miami Brain Symposium.